Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Purpose: Computed tomography (CT) is an effective method for detecting and characterizing lung nodules in vivo. With the growing use of chest CT, the detection frequency of lung nodules is increasing. Noninvasive methods to distinguish malignant from benign nodules have the potential to decrease the clinical burden, risk, and cost involved in follow‐up procedures on the large number of false‐positive lesions detected. This study examined the benefit of including perinodular parenchymal features in machine learning (ML) tools for pulmonary nodule assessment. Methods: Lung nodule cases with pathology confirmed diagnosis (74 malignant, 289 benign) were used to extract quantitative imaging characteristics from computed tomography scans of the nodule and perinodular parenchyma tissue. A ML tool development pipeline was employed using k‐medoids clustering and information theory to determine efficient predictor sets for different amounts of parenchyma inclusion and build an artificial neural network classifier. The resulting ML tool was validated using an independent cohort (50 malignant, 50 benign). Results: The inclusion of parenchymal imaging features improved the performance of the ML tool over exclusively nodular features (P < 0.01). The best performing ML tool included features derived from nodule diameter‐based surrounding parenchyma tissue quartile bands. We demonstrate similar high‐performance values on the independent validation cohort (AUC‐ROC = 0.965). A comparison using the independent validation cohort with the Fleischner pulmonary nodule follow‐up guidelines demonstrated a theoretical reduction in recommended follow‐up imaging and procedures. Conclusions: Radiomic features extracted from the parenchyma surrounding lung nodules contain valid signals with spatial relevance for the task of lung cancer risk classification. Through standardization of feature extraction regions from the parenchyma, ML tool validation performance of 100% sensitivity and 96% specificity was achieved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Finding Groups in Data: An Introduction to Cluster Analysis
Kaufman, L., & Rousseeuw, P. J. (1990) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316801 · Cited by 7,344
The relationship between Precision-Recall and ROC curves
Davis, J., & Goadrich, M. (2006) · Proceedings of the 23rd international conference on Machine learning - ICML '06 · doi:10.1145/1143844.1143874 · Cited by 6,559
Note on the Sampling Error of the Difference Between Correlated Proportions or Percentages
McNemar, Q. (1947) · Psychometrika · doi:10.1007/bf02295996 · Cited by 4,754
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491
Genetic epidemiology of copd (copdgene) study design
Regan, E. A., Hokanson, J. E., Murphy, J. R., Make, B., Lynch, D. A., Beaty, T. H., Curran-Everett, D., Silverman, E. K., & Crapo, J. D. (2011) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903499522 · Cited by 1,313 · cited 1×
“2,22,23 A subset of 50 subjects from the current 363 cohort was previously used to demonstrate the value of feature extraction from the lung parenchyma.”
MethodSelf-citationOverdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Cheng, J.-Z., Ni, D., Chou, Y.-H., Qin, J., Tiu, C.-M., Chang, Y.-C., Huang, C.-S., Shen, D., & Chen, C.-M. (2016) · Scientific Reports · doi:10.1038/srep24454 · Cited by 755 · cited 1×
“…inclusion of perinodular parenchymal features using both machine learning with AUC-ROC: 0.938 6 and 0.915 20 and deep learning methods have indirectly examined parenchymal inclusion with AUC-ROC of 0.993, 0.899, 0.946, 0.984 13,17–19 but the degree to which parenchyma has been included has varied.”
MethodInfluential
Cited by
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
Aggarwal, R., Sounderajah, V., Martin, G., Ting, D. S. W., Karthikesalingam, A., King, D., Ashrafian, H., & Darzi, A. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00438-z · Cited by 946
Risk-Based lung cancer screening: A systematic review
Toumazis, I., Bastani, M., Han, S. S., & Plevritis, S. K. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.07.007 · Cited by 270
FDA-regulated AI Algorithms: Trends, Strengths, and Gaps of Validation Studies
Ebrahimian, S., Kalra, M. K., Agarwal, S., Bizzo, B. C., Elkholy, M., Wald, C., Allen, B., & Dreyer, K. J. (2022) · Academic Radiology · doi:10.1016/j.acra.2021.09.002 · Cited by 120
Advances in artificial intelligence applications in the field of lung cancer
Yang, D., Miao, Y., Liu, C., Zhang, N., Zhang, D., Guo, Q., Gao, S., Li, L., Wang, J., Liang, S., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1449068 · Cited by 18
Metadata
- Authors
- Uthoff, J., Stephens, M. J., Newell, J. D., Hoffman, E. A., Larson, J., Koehn, N., De Stefano, F. A., Lusk, C. M., Wenzlaff, A. S., Watza, D., Neslund‐Dudas, C., Carr, L. L., Lynch, D. A., Schwartz, A. G., & Sieren, J. C.
- Venue
- Medical Physics
- Publisher
- Wiley
- Published
- 2019-06-07
- Volume
- 46
- Issue
- 7
- Pages
- 3207-3216
- ISSN
- 0094-2405 (ISSN-L)
- 2473-4209
- OpenAlex
- W2944970705
- Cited by
- 84
- References
- 8
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.